Log in to search using one of your social media accounts:

 

Summer program at UCLA helps build more diverse pipeline for health care field

For many college students, the summer break means basking at the beach, traveling to exotic locales or just hanging out with friends. But this summer meant something quite different to a dedicated group of college students from disadvantaged backgrounds. Thanks to a free program offered by the David Geffen School of Medicine at UCLA, these students took part in a six-week summer program to further their dreams of becoming health care professionals.“I was ecstatic about this opportunity and couldn’t wait to get involved,” said Nahun Flores, a 29-year-old who attends Chaffey College in Rancho Cucamonga, about 60 miles east of UCLA. Flores was one of 80 participants from underrepresented minorities and underprivileged backgrounds who have an interest in medicine, dentistry, nursing and other health professions who took advantage of theSummer Health Professions Education Program, known as SHPEP, for college sophomores, juniors and community college students.A native of Nicaragua, Flores said he is grateful for the opportunity to participate in the program, which was administered at the Geffen School of Medicine and 12 other U.S. sites, thanks to a generousgrant from the Robert Wood Johnson Foundation.“When we migrated to the U.S.,” Flores said, “we had access to health care; however we encountered many challenges because of health disparities. Facing those challenges and going through those experiences has impacted my character and made me real...
Source: UCLA Newsroom: Health Sciences - Category: Universities & Medical Training Source Type: news

Related Links:

Authors: Moskowitz CH PMID: 29036042 [PubMed - in process]
Source: Clinical Advances in Hematology and Oncology - Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research
Authors: PMID: 29036041 [PubMed - in process]
Source: Clinical Advances in Hematology and Oncology - Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research
Authors: Furman RR PMID: 29036040 [PubMed - in process]
Source: Clinical Advances in Hematology and Oncology - Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research
Authors: Johnson MS PMID: 29036039 [PubMed - in process]
Source: Clinical Advances in Hematology and Oncology - Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research
Authors: Johnson MS PMID: 29036038 [PubMed - in process]
Source: Clinical Advances in Hematology and Oncology - Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research
Authors: Zhu AX PMID: 29036037 [PubMed - in process]
Source: Clinical Advances in Hematology and Oncology - Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research
Authors: El-Serag HB PMID: 29036036 [PubMed - in process]
Source: Clinical Advances in Hematology and Oncology - Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research
Authors: El-Serag HB, Zhu AX, Johnson MS Abstract The treatment approach for hepatocellular carcinoma (HCC) depends on the stage and extent of disease, the severity of the underlying liver disease, and the overall performance status of the patient. Treatment consists of 4 main strategies: surgery (eg, resection and liver transplant), locoregional procedures (eg, ablation and transarterial embolization), systemic therapies, and best supportive care. For patients with early-stage tumors, surgical treatment or ablation can be curative. Patients with intermediate-stage disease can be candidates for embolization, admini...
Source: Clinical Advances in Hematology and Oncology - Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research
Authors: Mazighi M Abstract The therapeutic management of acute ischemic stroke has changed tremendously over the past few years. Mechanical thrombectomy in addition to intravenous tissue plasminogen activator (t-PA) is currently the standard of care for patients experiencing acute ischemic stroke as a consequence of large vessel occlusion of the anterior circulation. Yet, despite strong evidence supporting such a therapeutic approach, several issues remain a source of debate, such as the need for intravenous t-PA, the optimal target for blood pressure levels and the opportunity for additional antithrombotic therap...
Source: Revue Neurologique - Category: Neurology Tags: Rev Neurol (Paris) Source Type: research
Authors: Detante O, Rome C, Papassin J Abstract Regenerative cell therapy is a promising therapeutic strategy in neurology, most notably to improve stroke recovery. Although tolerability and feasibility have apparently been validated, many questions remain as to what is the best type of cells to use, the best route and the post-stroke delay for administration. Two main strategies have currently emerged: intravenous injection of mesenchymal stem cells with systemic trophic support; and intracerebral grafting of neural stem cells with brain repair effects at the lesion site. Multicenter clinical trials have just begu...
Source: Revue Neurologique - Category: Neurology Tags: Rev Neurol (Paris) Source Type: research
More News: Cardiology | Children | Dentistry | Education | Health Management | Heart | Learning | Men | Nicaragua Health | Nurses | Nursing | Students | Study | Universities & Medical Training | Workshops